Skip to main content
. 2012 Jun 18;6:258. doi: 10.3332/ecancer.2012.258

Table 5. Performance of high-risk HPV-DNA testing + cytology in predicting residual/recurrent CIN [5, 6].

Sensitivity 96% (95% CI 89–99)
Specificity 81% (95% CI 77–84)
PPV 46% (95% CI 38–54)
NPV 99% (95% CI 98–100)
PPV positive predictive value, NPV negative predictive value